A study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.
An Australian-led study will investigate whether it’s possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.The study will explore the immune response to COVID-19-specific va
Study explores the immune response to COVID-19-specific vaccines in Brazilian healthcare workers
An Australian-led study will investigate whether it s possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.
The study will explore the immune response to COVID-19-specific vaccines in Brazilian healthcare workers to find biomarkers that indicate whether someone will be protected from - or remains at risk of - contracting COVID-19 if exposed to a variant.
The research has received philanthropic funding from the Bill & Melinda Gates Foundation and is a sub-study of the Murdoch Children s Research Institute s (MCRI) study assessing if the Bacille Calmette-Guérin (BCG) vaccine can help protect against COVID-19.
Gov t urged to start random testing for new COVID-19 variant LISTEN
JAN 28, 2021
Dr. John Amuasi, a Senior Research Fellow, Global Health and Infectious Diseases Research Group, believes a new variant of the covid-19 is responsible for the recent surge in cases and increased deaths.
He has urged the government to set routine surveillance sites across the country to better assess the situation.
Speaking on the
Citi Breakfast Show, Dr. Amuasi said the testing needed to be “randomly done on a regular basis every day or every two to three days so that we can truly measure our rate of spread.”